| Primary |
| Prostate Cancer |
50.0% |
| Type 2 Diabetes Mellitus |
50.0% |
|
| Glucose Tolerance Impaired |
100.0% |
|
| Secondary |
| Prostate Cancer |
31.1% |
| Product Used For Unknown Indication |
17.5% |
| Benign Prostatic Hyperplasia |
9.7% |
| Diabetes Mellitus |
6.8% |
| Prostate Cancer Stage Ii |
4.9% |
| Skin Ulcer |
3.9% |
| Urinary Tract Infection |
3.9% |
| Gout |
2.9% |
| Hypertension |
2.9% |
| Carotid Artery Stenosis |
1.9% |
| Depression |
1.9% |
| Gastritis |
1.9% |
| Mental Disorder |
1.9% |
| Prostate Cancer Stage Iii |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Dysmenorrhoea |
1.0% |
| Gastroenteritis |
1.0% |
| Hormone Replacement Therapy |
1.0% |
| Hypersensitivity |
1.0% |
| Hypertonic Bladder |
1.0% |
|
| Liver Disorder |
21.2% |
| Diabetes Mellitus |
9.1% |
| Malaise |
9.1% |
| Jaundice |
6.1% |
| Ocular Icterus |
6.1% |
| Pregnancy |
6.1% |
| Abortion Spontaneous |
3.0% |
| Bacteraemia |
3.0% |
| Dermatitis Exfoliative |
3.0% |
| Drug Interaction |
3.0% |
| Dry Mouth |
3.0% |
| Gamma-glutamyltransferase Increased |
3.0% |
| Hepatitis Acute |
3.0% |
| Hyponatraemia |
3.0% |
| Lipids Increased |
3.0% |
| Muscular Weakness |
3.0% |
| Palpitations |
3.0% |
| Pruritus |
3.0% |
| Pyrexia |
3.0% |
| Sepsis |
3.0% |
|
| Concomitant |
| Prostate Cancer Stage Iv |
40.4% |
| Product Used For Unknown Indication |
7.5% |
| Prostate Cancer Stage Ii |
7.5% |
| Prostate Cancer |
7.4% |
| Drug Use For Unknown Indication |
6.6% |
| Benign Prostatic Hyperplasia |
4.7% |
| Hypertension |
3.8% |
| Constipation |
3.3% |
| Cancer Pain |
2.8% |
| Gastritis |
2.2% |
| Diabetes Mellitus |
1.8% |
| Pyelonephritis |
1.8% |
| Colon Cancer |
1.6% |
| Metastases To Liver |
1.4% |
| Prostate Cancer Recurrent |
1.4% |
| Urinary Incontinence |
1.4% |
| Lipid Metabolism Disorder |
1.2% |
| Cerebral Infarction |
1.1% |
| Gastric Ulcer |
1.1% |
| Lupus Nephritis |
1.1% |
|
| Prostate Cancer |
17.1% |
| Prostate Cancer Stage Iv |
13.7% |
| Pneumonia |
8.5% |
| Prostatic Specific Antigen Increased |
7.7% |
| Pleural Effusion |
5.1% |
| Renal Failure Acute |
5.1% |
| Interstitial Lung Disease |
4.3% |
| Cerebral Infarction |
3.4% |
| Chronic Respiratory Failure |
3.4% |
| Death |
3.4% |
| Hypoglycaemia |
3.4% |
| Marasmus |
3.4% |
| Pyrexia |
3.4% |
| Cervix Carcinoma |
2.6% |
| Injection Site Induration |
2.6% |
| Liver Disorder |
2.6% |
| Metastases To Bone |
2.6% |
| Oedema |
2.6% |
| Oedema Peripheral |
2.6% |
| Peritonitis Bacterial |
2.6% |
|
